发明名称 THE ALTERATION OF SIGNAL TRANSDUCTION BY APPLYING CULTURED CELL LINE WITH ANTAGOMERIC DNA ANTISENSE OLIGMER TARGETING HSA-MIR-106B MIRNA
摘要 <p>PURPOSE: A treatment of an in vitro cultured cell line with an antisense DNA oligomer of hsa-miR-106b miRNA and a method for changing a signal transduction system are provided to show the same effect as endorphin by adding an antagomer or miRNA which has the same sequence as the antagomer using hsa-miR-106b miRNA. CONSTITUTION: A method for promoting the expression of hsa-miR-106b target proteins comprises the step of treating an in vitro cultured cell line with an antisense DNA oligomer of hsa-miR-106b. The proteins are eukaryotic translation initiation factor 5A2, zinc finger/NFX1-type containing 1, FYVE and coiled-coil domain containing 1, polycystic kidney disease 2 (autosomal dominant), programmed cell death 1 ligand 2, cytochrome b reductase 1, pleckstrin homology domain containing- family A (phosphoinositide binding specific) member 3, myelin transcription factor 1-like, N-acyl phosphatidylethanolamine phospholipase D, and ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative function). The expression level of the proteins is reduced by allowing hsa-miR-106b miRNA to target mRNA of a specific molecule.</p>
申请公布号 KR20130083981(A) 申请公布日期 2013.07.24
申请号 KR20120004628 申请日期 2012.01.16
申请人 KIM, SEUNG CHAN 发明人 KIM, SEUNG CHAN
分类号 C12N15/63;C12N15/113;C12N15/67;C12Q1/68 主分类号 C12N15/63
代理机构 代理人
主权项
地址